Next |
home / stock / ptn / ptn message board
Subject | By | Source | When |
---|---|---|---|
HW says worth 75$ let start with 20$ | zeusgodmd | investorshub | 04/28/2023 5:09:07 PM |
Nice buys by me today longer term pay | zeusgodmd | investorshub | 04/28/2023 4:36:22 PM |
Amen brother. :) | chantillylive | investorshub | 04/24/2023 1:15:34 PM |
$Article on bio pharm companies cheap and getting | zeusgodmd | investorshub | 04/21/2023 11:49:22 AM |
Decent move on preliminary quarterly results for Vyleesi. | mike1986 | investorshub | 04/19/2023 6:11:58 PM |
Current fins getting attention of this stock but | zeusgodmd | investorshub | 04/19/2023 5:39:54 PM |
When it goes it will fly it will | zeusgodmd | investorshub | 04/19/2023 12:39:23 PM |
Not going anywhere Zeus. I have this | mike1986 | investorshub | 04/19/2023 12:38:10 PM |
Mike we are good here dry eye and | zeusgodmd | investorshub | 04/18/2023 9:53:10 PM |
We should only be so fortunate. | mike1986 | investorshub | 04/18/2023 3:28:22 PM |
HW has a buy for goal price of | zeusgodmd | investorshub | 04/18/2023 2:50:26 PM |
Prometheus got bought out on Monday buy Merck | zeusgodmd | investorshub | 04/18/2023 2:48:56 PM |
Different Ibs drug today doubled its share value | zeusgodmd | investorshub | 04/05/2023 3:27:00 PM |
Hmm...whales taking profits again after a small runup. | mike1986 | investorshub | 03/28/2023 4:20:52 PM |
Something is going on. Anyone know what | mike1986 | investorshub | 03/23/2023 3:44:42 PM |
Merck or pfizer could not do that its | zeusgodmd | investorshub | 03/22/2023 8:17:39 PM |
At this point why would anyone pay $70/s | mike1986 | investorshub | 03/22/2023 7:01:34 PM |
We need a buyout that why this is | zeusgodmd | investorshub | 03/22/2023 6:03:37 PM |
First we need to get to $7 lol. | mike1986 | investorshub | 03/22/2023 12:38:25 AM |
Not 70 dollars yet but a start | zeusgodmd | investorshub | 03/21/2023 6:58:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Palatin Technologies Inc. Company Name:
PTN Stock Symbol:
NYSE Market:
Palatin Technologies Inc. Website:
Palatin Announces Exercise of Warrants for Approximately $6.1 Million Gross Proceeds PR Newswire CRANBURY, N.J. , June 21, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company developing fi...
Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction (ED) PR Newswire In ED patients that do not respond to PDE5i monotherapy ~30-40% of ED patients do not respond to PDE5...
Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity PR Newswire Co-Administration Phase 2 study of bremelanotide with tirzepatide (GLP-1) to provide key information for melanocortin treatments of obesity Topline data expected by end...